FDA Approval Rounded Out a Successful 2014 for Cancer Immunotherapy
Cancer immunotherapy, which entered 2014 with the accolade of Science magazine’s Breakthrough of the Year for 2013, ended the...
Cancer immunotherapy, which entered 2014 with the accolade of Science magazine’s Breakthrough of the Year for 2013, ended the...
Guest Post by T.J. Sharpe Originally appeared on Philly.com's Patient #1 blog
Rarely do investigators in two distinct fields of cancer research have the time to come together for an evening...
Yesterday, the U.S. Food and Drug Administration (FDA) announced the highly anticipated approval of the cancer immunotherapeutic pembrolizumab (Keytruda)...
What is cancer immunotherapy, how does it work, and why are people so excited about it?
When I was a child, the proximity of the Jersey Shore to my hometown made the beach a frequent...